Publications by authors named "Guillem Pons"

Claim this Profile
T
TRIB3 silencing promotes the downregulation of Akt pathway and PAX3-FOXO1 in high-risk rhabdomyosarcoma.
Gabriel Gallo-Oller, Guillem Pons, Júlia Sansa-Girona, Natalia Navarro, Patricia Zarzosa

Exp Hematol Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Cancer Genomic Amplifications Identifies Druggable Collateral Dependencies within the Amplicon.
Guillem Pons, Gabriel Gallo-Oller, Natalia Navarro, Patricia Zarzosa, Júlia Sansa-Girona

Cancers (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the Hedgehog Pathway in Rhabdomyosarcoma.
Patricia Zarzosa, Lia Garcia-Gilabert, Raquel Hladun, Gabriela Guillén, Gabriel Gallo-Oller, Guillem Pons

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastoma.
Natalia Navarro, Carla Molist, Júlia Sansa-Girona, Patricia Zarzosa, Gabriel Gallo-Oller, Guillem Pons, Berta Ponsati

Cell Mol Life Sci· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dickkopf-1 Inhibition Reactivates Wnt/β-Catenin Signaling in Rhabdomyosarcoma, Induces Myogenic Markers In Vitro and Impairs Tumor Cell Survival In Vivo.
Irina Giralt, Gabriel Gallo-Oller, Natalia Navarro, Patricia Zarzosa, Guillem Pons

Int J Mol Sci· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dickkopf Proteins and Their Role in Cancer: A Family of Wnt Antagonists with a Dual Role.
Irina Giralt, Gabriel Gallo-Oller, Natalia Navarro, Patricia Zarzosa, Guillem Pons

Pharmaceuticals (Basel)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Mechanism-Based Sphingosine-1-phosphate Lyase Inhibitor.
Guillem Pons, Daniel Riba, Mireia Casasampere, Eduardo Izquierdo, José-Luís Abad

J Org Chem· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of age and comorbidities in mortality of patients with infective endocarditis.
Carlos Armiñanzas, Concepción Fariñas-Alvarez, Jesús Zarauza, Patricia Muñoz, Víctor González Ramallo, Guillem Pons

Eur J Intern Med· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-Year Results of Bioresorbable Vascular Scaffolds for Coronary Chronic Total Occlusions.
Beatriz Vaquerizo, Antonio Barros, Sandra Pujadas, Ester Bajo, Marcelo Jiménez, Guillem Pons

Am J Cardiol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors determining success in percutaneous revascularization of chronic total coronary occlusion: multidetector computed tomography analysis.
Victoria Martín-Yuste, Antonio Barros, Ruben Leta, Ignacio Ferreira, Salvatore Brugaletta, Guillem Pons

Rev Esp Cardiol (Engl Ed)· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis